MedPath

Promoting the Use of CPAP Therapy Among OSA Patients

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Behavioral: CPAP4HealthySleep system
Registration Number
NCT04372329
Lead Sponsor
Sarah Alismail
Brief Summary

Obstructive sleep apnea (OSA) is the most common sleep breathing disorder in the U.S. Continuous Positive Airway Pressure (CPAP) therapy is the most effective treatment for OSA. However, up to 50% of patients who accept using CPAP therapy fail to adhere to it. This study will evaluate an information systems (IS)-based solution that sends tailored, motivational, educational messages and tailored feedback messages to promote CPAP usage among noncompliant OSA patients. The primary aim of this study is to determine the efficacy of the proposed IS solution and its effect on fostering the use of CPAP therapy among OSA patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Clinical diagnosis of OSA
  • Prescribed treatment of CPAP therapy
  • Possession of a mobile phone that has multimedia messaging capabilities
  • Capacity to consent.
Exclusion Criteria
  • Unable to speak and read English

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
CPAP4HealthySleep: System 2 (BABA)CPAP4HealthySleep systemParticipants in this group will first receive weekly feedback messages only (one message per week) notifying participants of their CPAP usage for two weeks (type B). Next, they will receive six tailored educational messages per week and weekly feedback messages notifying participants of their CPAP usage on the seventh day for two weeks (type A), re-introduction of type B for another two weeks, followed by re-introduction of type A for two weeks.
CPAP4HealthySleep: System 1 (ABAB)CPAP4HealthySleep systemParticipants in this group will first receive six tailored educational messages per week and weekly feedback messages notifying participants of their CPAP usage on the seventh day for two weeks (type A). Next, they will receive weekly feedback messages only (one message per week) notifying participants of their CPAP usage for two weeks (type B), re-introduction of type A for another two weeks, followed by re-introduction of type B for two weeks.
Primary Outcome Measures
NameTimeMethod
CPAP compliance19 weeks

Compliance of CPAP use characterized by mask-on time at the prescribed pressure for ≥ 4 hours/day for 70% of monitored nights.

Change in CPAP usageDuring 19 weeks

The average number of hours per week of CPAP usage.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pomona Valley Hospital Medical Center Adults and Children Sleep Disorders Center

🇺🇸

Claremont, California, United States

© Copyright 2025. All Rights Reserved by MedPath